November 13-14, 2023
Welcome to Nashville – Introductions
STATE of the HEALTHCARE M&A INDUSTRY
The conference opens with a Keynote panel discussion on the “State of the Healthcare M&A Industry” from the perspective of the proverbial ’30-thousand feet.’ Leading healthcare experts with first-hand information will focus this discussion on – among other things:
- Higher Interest Rates, Increased Cost-of Staffing & Reduced and Lagging Reimbursements: How widespread is the Distress in the Urban and Rural Hospital Sector?
- How are transactions being affected by the latest actions from State and Washington policymakers?
- Life Sciences, Medical Devices, Clinical Research Organizations & non-Hospital Providers: How are these Ancillary Markets Doing?
- What is the outlook for middle-market M&A and Partnerships transactions in the next 12 to 18 months?
Distressed Opportunities in the Medical Device, Life Science & Other Specialty Sectors
- Life Sciences, Medical Devices, Clinical Trial Management, Orthopedic and Home Healthcare providers: Which sectors are showing particular vulnerability to bankruptcy and distressed situations?
- Where are Financial and Strategic Opportunity Buyers focusing their attention over the next 12- to 18-months in these sectors?
PM NETWORKING BREAK, REFRESHMENTS & INFORMAL DISCUSSIONS
Metro & Rural Hospital M&A Roundtable
- What does 2024 hold in store for deal-flow in the for-profit and non-profit Hospital sectors?
- How are pressures from inflation, staffing shortages, low operating margins, high interest rates & looming debt refinancing affecting the Metropolitan and Rural Hospital Sectors?
- Will the gap between High-Performing and Struggling Hospitals continue to grow?
Roll-Ups and Multi-Physician Practices
- Hospital- and Private Equity-driven Roll-ups in the Physician Practice Sector now employ over 50% of Physicians in the US. Will this trend continue?
- How has the ‘physician-as-employee” model been affecting the growth of Specialty Ambulatory Providers?
- In this atmosphere, which specialty practices, (for example, mental health, orthopedic, dental, vision, & etc.) are drawing the most investor attention?
DAY ONE CONFERENCE SESSIONS CONCLUDE
Evening Networking Reception
DAY TWO: Tuesday, November 14, 2023
REGISTRATION & CONTINENTAL BREAKFAST
Transaction Services Roundtable
An examination of best practices in enhancing seller valuations, regulatory compliance, due diligence and more.
- What are the “dos and don’ts” before, during and after a healthcare transaction?
- Transaction War Stories: Who has the best “You’ll-never-believe-what-happened” story to share?
Will 2023 – 2024 be a ‘Buyers’ or a ‘Sellers’ Market?
Healthcare Partnerships & Joint Ventures Roundtable
- When does it make more sense to enter into joint ventures and partnerships than to execute outright mergers or acquisitions?
- How are these partnerships and joint-venture deals being structured?
- How are debt restructuring pressures affecting the decisions to enter into partnerships and joint ventures vs. traditional M&A deals?
LUNCHEON FOR ALL CONFERENCE PARTICIPANTS
Distressed & Turnaround Opportunities in Healthcare
- Post-pandemic, the Middle-Market Healthcare sector has been among the top enterprise verticals experiencing distress and bankruptcy pressures.
- Chapter 11 filings in the Healthcare Services sector in the first half of 2023 are up dramatically over the same period in 2022 – and the Southeastern United States leads all other regions of the country by far in Healthcare C-11 filings.
- From Rural Hospitals to the Senior Housing, disruption in these markets produces both distress AND opportunity.
- This roundtable discussion will focus on how opportunity investors, bankruptcy and turnaround specialists and others are assessing the landscape for ROI when investing in these distressed healthcare spaces in 2024 and beyond.
Healthcare Lenders Roundtable
- How are Alternative and Brick-and-Mortar lenders competing for Healthcare M&A Deal-flow business in today’s high interest rate environment?
- What are the top-of-mind considerations on the buy-side when marshalling leverage in today’s healthcare environment?
- How are higher interest rates affecting sell-side valuations?
- Which sectors – including healthcare, biotech, life sciences and medical devices – are lenders favoring when green-lighting new originations and re-financing deals?
iiBIG Thanks ALL OF OUR clients, for over FIFTEEN Years of Healthcare Deal-Making Leadership!
CONTINUING EDUCATION CREDITS
Continuing Education Credits (e.g. CLE, CPE, CME, etc.) may be available for iiBIG conference attendees. Upon request conference attendees will be provided with a “Certificate of Attendance” and a copy of the conference agenda, showing topics, length of sessions, and name(s) and professional affiliation(s) of presenter(s) for each session. Attendees wishing to apply for continuing education credits for attending this conference may submit this documentation to the relevant organization in his/her state when applying for such credits.
International Institute for Business Information & Growth LLC is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.